Aimmune Therapeutics, Inc.

ARMISTICE CAPITAL, LLC

Report date

6/30/2020

Quarter

2020 Q2

Filed

8/14/2020

Shares

924,000

Value ($000)

15,440

Weight

0.8%

2020 Q1 - 2020 Q2 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q2	8/14/2020	15,440	0.8%	924,000	6/30/2020
2020 Q1	5/15/2020	8,652	0.6%	600,000	3/31/2020